Blood-based biomarkers of microvascular pathology in Alzheimer’s disease
- 25 September 2009
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 45 (1) , 75-79
- https://doi.org/10.1016/j.exger.2009.09.005
Abstract
No abstract availableKeywords
Funding Information
- Health Service Executive
- Science Foundation Ireland (08/IN.1/B1846)
- National Institutes of Health (1R21AG028754, R21NS060271-01)
- Health Research Board
This publication has 39 references indexed in Scilit:
- Serum sphingomyelins and ceramides are early predictors of memory impairmentNeurobiology of Aging, 2010
- Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly menAtherosclerosis, 2009
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer diseaseExperimental Gerontology, 2009
- New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's DiseaseNeurotherapeutics, 2008
- Associative and predictive biomarkers of dementia in HIV-1–infected patientsNeurology, 2007
- Immunoluminometric Assay for Measurement of the C-Terminal Endothelin-1 Precursor Fragment in Human PlasmaClinical Chemistry, 2006
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrierLife Sciences, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984